Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 16, 2025
Reporting period
Not applicable
Filed with the SEC
Nov 18, 2025
CEOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001171843-25-007400
Filed / recorded
Nov 18, 2025, 1:30 PM UTC
Added to OQRO
Oct 7, 2026, 10:28 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Compass Therapeutics, Inc.
Issuer CIK
1738021
Ticker
CMPX
Reporting person
Thomas J. Schuetz
Relationship
Director, Officer
Officer title
CHIEF EXECUTIVE OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Nov 16, 2025
Transaction code
F
Shares / units
44,025
Price per share
$4.83
Acquired / disposed
Disposed (D)
Shares owned after
6,436,800
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
250,000 of the shares represent unvested restricted stock units ("RSU") granted on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 478,125 of the shares represent unvested restricted stock units ("RSU") granted on January 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.